RANKVET: A new ranking method for comparing and prioritizing the environmental risk of veterinary pharmaceuticals

被引:20
|
作者
Di Nica, Valeria [1 ]
Menaballi, Luca [2 ]
Azimonti, Giovanna [2 ]
Finizio, Antonio [1 ]
机构
[1] Univ Milano Bicocca, Dept Earth & Environm Sci, I-20126 Milan, Italy
[2] Int Ctr Pesticides & Hlth Risk Prevent ICPS, Milan, Italy
关键词
Veterinary pharmaceuticals; Risk indicators; Risk management; Ranking; Italy; HAZARD ASSESSMENT; TOXICITY; ANTIBIOTICS; MEDICINES; CLASSIFICATION; IVERMECTIN; EXPOSURE; AREAS;
D O I
10.1016/j.ecolind.2014.12.021
中图分类号
X176 [生物多样性保护];
学科分类号
090705 ;
摘要
In recent years veterinary medicinal products (VMPs) have been recognized as emerging contaminants, giving rise to concerns regarding their environmental impact. Due to the high number of utilized VMPs, it is necessary to develop tools (indicators) for ranking these compounds according to their environmental risk relevance. These indicators can be useful, for example, for setting up monitoring programmes, and more in general for risk management purposes. In this paper we propose a new scoring system method (RANKVET) that enables ranking the risk of VMPs for aquatic and terrestrial organisms. The procedure is fully based on the information required by the EU Directives and Regulations for marketing authorization of VMPs and Veterinary International Conference on Harmonization (VICH) guidelines. According to the latter, if the environmental risk assessment of a VMP indicates an unacceptable risk to the environment, i.e., the risk quotient (RQ) consisting of the ratio of Predicted Environmental Concentration (PEC) to Predicted No Effect Concentration (PNEC) is >= 1, then mitigation measures should be proposed by the applicant in order to reduce the risk to an acceptable level. If a risk mitigation measure does not fulfil the criteria mentioned above then the outcome of the risk assessment is that a serious risk for the environment exists. In accordance with Directive 2001/82/EC (as amended) this risk has to be weighed against the favourable aspects of a marketing authorization. The prioritization scheme is based on a quantitative approach and consist of different phases. First, for each VMP, PECs are calculated using simple exposure models and worst case assumptions. PNECs are calculated for non-target organisms representative of the considered ecosystems (soil or surface water). Then numerical scores are given to the calculated PEC/PNEC ratio. Finally, the obtained score is multiplied with a further score which is based on the relevance of the metabolic rate in animals. RANKVET can be applied for surface water and soil systems and for different farming methods (intensive or pasture) and treated species. As an example of its potential use we applied RANKVET to 48 VMPs largely utilized in Italy. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:270 / 276
页数:7
相关论文
共 42 条
  • [1] Prioritizing environmental risk of prescription pharmaceuticals
    Dong, Zhao
    Senn, David B.
    Moran, Rebecca E.
    Shine, James P.
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2013, 65 (01) : 60 - 67
  • [2] Quantification of pharmaceuticals in hospital effluent: Weighted ranking of environmental risk using a fuzzy hybrid multicriteria method
    Becker, Raquel Wielens
    Cardoso, Renata Martins
    Dallegrave, Alexsandro
    Ruiz-Padillo, Alejandro
    Sirtori, Carla
    [J]. Chemosphere, 2023, 338
  • [3] Environmental risk assessment of veterinary pharmaceuticals in the EU: Reply to Montforts and de Knecht
    Long, C
    Crane, M
    [J]. TOXICOLOGY LETTERS, 2003, 142 (03) : 219 - 225
  • [4] Overview of the US Food and Drug Administration Center for Veterinary Medicine environmental risk assessment process for veterinary pharmaceuticals
    Zahner, Holly M.
    Hunter, Wesley
    Silberhorn, Eric
    Eirkson, Charles
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [5] RANKING PRESCRIBED PHARMACEUTICALS IN TERMS OF ENVIRONMENTAL RISK: INCLUSION OF HOSPITAL DATA AND THE IMPORTANCE OF REGULAR REVIEW
    Helwig, Karin
    Hunter, Colin
    McNaughtan, Moyra
    Roberts, Joanne
    Pahl, Ole
    [J]. ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2016, 35 (04) : 1043 - 1050
  • [6] Environmental risk assessment of veterinary pharmaceuticals:: Development of a standard laboratory test with the dung beetle Aphodius constans
    Roembke, J.
    Hempel, H.
    Scheffczyk, A.
    Schallnab, Ha.
    Alvinerie, M.
    Lumaret, J. -P.
    [J]. CHEMOSPHERE, 2007, 70 (01) : 57 - 64
  • [7] An overview of the use of quantitative structure-activity relationships for ranking and prioritizing large chemical inventories for environmental risk assessments
    Russom, CL
    Breton, RL
    Walker, JD
    Bradbury, SP
    [J]. ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2003, 22 (08) : 1810 - 1821
  • [8] Ranking environmental aspects in environmental management systems: A new method tested on local authorities
    Marazza, Diego
    Bandini, Vittoria
    Contin, Andrea
    [J]. ENVIRONMENT INTERNATIONAL, 2010, 36 (02) : 168 - 179
  • [9] Occurrence of pharmaceuticals in surface waters: analytical method development and environmental risk assessment
    Nannou, Christina I.
    Kosma, Christina I.
    Albanis, Triantafyllos A.
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL ANALYTICAL CHEMISTRY, 2015, 95 (13) : 1242 - 1262
  • [10] Results of extended plant tests using more realistic exposure scenarios for improving environmental risk assessment of veterinary pharmaceuticals
    Richter, Elisabeth
    Berkner, Silvia
    Ebert, Ina
    Foerster, Bernhard
    Graf, Nadin
    Herrchen, Monika
    Kuehnen, Ute
    Roembke, Jorg
    Simon, Markus
    [J]. ENVIRONMENTAL SCIENCES EUROPE, 2016, 28